Daily screen · FRI 09 OCT 2026

Stock
Guru

Confirmation-triggered inflection screen. Fundamentals · technicals · sentiment, accounting red flags filtered, analyst-researched verdicts. Bot flags — Max decides. Flag-only: nothing here is validated or investment advice.

16fresh triggers
2verified genuine
62watchlist
239rejected

Top picks

ranked: fundamentals 45 / technicals 35 / sentiment 20 · analyst verdicts re-rank
01 HTFL Heartflow, Inc.
$47.63price 9%off high $4.1Bmcap 57dsince 10-Q
+41%2025-09 → +41%2026-03 → +48%2026-06
FUND
61margin up
TECH
90RS +79% vs SPY / vol x1.09
SENT
40insiders -11 / SI 9% / 9 analysts
Surgical & Medical Instruments & Apparatus
genuine inflection candidate organic ramp

What happenedQ2 2026 (reported 13 Aug 2026) revenue was $64.1M, +48% YoY, driven organically: total cases up 74% to 84,491 on higher utilization at existing sites plus new account activations, plus Plaque revenue of $7.8M (~$4M ahead of plan). No acquisitions. FY2026 guidance raised to $246-250M from $228-232M.

BullRecurring per-analysis SaaS-like model at ~83% gross margin, case volume up 74%, Plaque ramping ahead of plan, and a CMS 2027 tailwind (CCTA payment up ~12%, FFR-CT/Plaque stable) supporting adoption; management raised full-year guidance.

BearStill deeply loss-making (net operating loss $17.9M, EPS -$0.18), a recent IPO with weak third-party quality scores and warning flags; growth is decelerating at the full-year level (guide ~40-42% vs 48% in-quarter) and a lofty medtech valuation leaves little room for a volume stumble.

NarrativePositive post-print ('revenue surges 48%, plaque momentum'), guidance raise and margin expansion; a 2025 IPO ($19 offer) so retail interest and valuation risk are elevated and some screens flag caution. Lockup already expired 4 Feb 2026, so that overhang is behind rather than ahead.

Repeat purchaseYes - per-scan analysis model; revenue scales with recurring case volume (84,491 cases, +74%)
OrganicYes - volume plus new accounts plus Plaque, no M&A
DistributionExpanding - new account activations tracking to ~1,250 by year-end; US revenue +51%
What kills itReimbursement reversal or slower hospital adoption; continued cash burn forcing dilution; IPO froth unwinding
02 NTAP Netapp, Inc.
$231.05price 2%off high $45.4Bmcap 37dsince 10-Q
+3%2025-10 → +4%2026-01 → +30%2026-07
FUND
51margin flat / CFO-NI 1.62
TECH
80RS +37% vs SPY / vol x0.97
SENT
30insiders -13 / SI 5% / 16 analysts
Computer Storage Devices
genuine inflection candidate organic ramp

What happenedNetApp reported record Q1 FY2027 revenue (quarter ended ~2026-07-31, reported late Aug 2026) of $2.03B, +30% YoY versus $1.56B, so the screener's +29.9% is REAL, not a data artifact. Growth was led by all-flash-array revenue of $1.31B (+47% YoY) and product revenue +51% on AI/data-infrastructure demand, though a 14th fiscal week (53-week FY2027) inflated the headline by ~3 points.

BullAll-flash-array revenue hit a record $1.31B (+47% YoY) as enterprises buy NetApp storage for AI workloads, and management raised FY2027 guidance to $7.975-8.225B revenue and non-GAAP EPS $9.73-10.03 (~22% growth at midpoint), signalling durable demand rather than a one-quarter blip.

BearRoughly 3 points of the 30% headline came from a non-recurring extra fiscal week, and this is a cyclical hardware-led storage business, so a +51% product quarter sets a brutal comp that could decelerate sharply in FY2028 if AI capex digests.

NarrativeStrongly positive - record revenue and record EPS ($2.58), raised full-year guidance, and management framing NetApp as an AI/hybrid-multicloud platform winner; analyst reaction favourable with the AI-storage demand cycle the key catalyst. Note the extra-week/tough-comp caveat tempers the clean read.

Repeat purchaseSticky enterprise installed base plus ratable support (~$720M) and public cloud (~$206M) revenue
OrganicYes - AFA/AI demand driven; the DataPelago acquisition is too small to move revenue
DistributionEstablished channel plus first-party hyperscaler cloud partnerships (AWS/Azure/Google)
What kills itAI capex digestion, lapping the 14-week comp, and storage pricing/cyclicality
03 FF Futurefuel Corp.
$5.18price 19%off high $227Mmcap 60dsince 10-Q
-56%2025-09 → +82%2026-03 → +121%2026-06
FUND
95margin up
TECH
55RS +7% vs SPY / vol x0.86
SENT
30insiders +0 / SI 5%
Industrial Organic Chemicals
needs human judgement commodity/cyclical

What happenedQ2 2026 revenue (reported 11 Aug 2026) was $78.7M, +120.7% YoY vs $35.7M, driven by the biofuels segment (+176.9% to $52.9M) swinging from a $13.5M gross loss a year ago to a $10.1M gross profit on restored plant reliability - roughly half price (blended price +80.2%) and half volume (total +40.4%, biofuel production +21%), off a badly depressed outage-plagued base, plus 45Z/RFS regulatory clarity.

BullReal operational turnaround: volume +40.4%, swung to $11.4M net income and $11.8M adj. EBITDA, and management (11 Aug) sees no factors to 'dramatically disrupt' current biodiesel margins; a 4-year deal to monetize Section 45Z/small-producer credits adds ~$22M gross proceeds in H2.

BearGrowth is a cyclical rebound off a depressed base leaning on an +80.2% blended-price surge tied to RIN/45Z/BTC economics, not durable demand; elevated soybean-oil feedstock still pressures margins and the $22M credit monetization is largely one-off cash, so the comp normalizes hard next year.

NarrativeShares jumped on the 11 Aug 2026 swing-to-profit with upbeat trade-press coverage framing a biofuels rebound; no formal analyst ratings/targets surfaced, and the micro-cap retail buzz is policy-tailwind driven. Near-term catalysts are the Q3/Q4 45Z credit proceeds and EPA RFS volume rules.

Repeat purchaseCommodity offtake, not sticky subscription; demand follows mandates/prices
OrganicYes, organic (no acquisition) - internal plant reliability + volume recovery
DistributionEstablished biodiesel/chemical channels; 4-yr 45Z credit monetization agreement in place
What kills it45Z/RFS policy change, RIN/credit price collapse, or soybean-oil cost spike compressing margins back to losses
04 EGY Vaalco Energy Inc /De/
$6.00price 8%off high $631Mmcap 60dsince 10-Q
-57%2025-09 → -43%2026-03 → +40%2026-06
FUND
55margin ?
TECH
90RS +7% vs SPY / vol x1.07
SENT
50insiders +0 / SI 8% / 2 analysts
Crude Petroleum & Natural Gas
needs human judgement commodity/cyclical

What happenedQ2 2026 revenue was $135.2M (reported 6 Aug 2026), up ~39.5% YoY and +$72.6M from Q1 2026, but the swing was driven by lifting timing - net sales volumes jumped 47% QoQ (two Gabon partner liftings of ~900k bbl gross each landed in Q2) while actual production rose only ~10% QoQ - plus higher realized oil prices. The prior quarter's -43.3% YoY was the mirror image: few liftings recognized.

BullBeneath the lifting noise a real organic ramp is beginning: the Baobab (Cote d'Ivoire) FPSO restarted June 2026 with first crude lifting Aug 2026, and Q3 2026 production is guided +23% QoQ, so forward volume growth is genuine; Q2 adjusted EBITDAX of $54.8M (nearly 5x Q1) shows strong cash generation when liftings and prices align.

BearThe +39.5% headline is largely a lifting-timing artifact off a weak comp plus oil price, not a step-change in output; sales exceeded production as inventory was drawn down, so the spike is not repeatable and reverses in a low-lifting quarter. Revenue stays hostage to cargo scheduling and Brent.

NarrativeNarrative was positive - large EPS beat ($0.39 vs ~$0.05 consensus), shares up ~8% on the print, framed as a strong Q2 turnaround with +23% Q3 production guidance as the forward catalyst; reaction leaned on the operational turnaround (Baobab restart) more than the lifting-driven revenue line.

Repeat purchaseLumpy cargo sales, not recurring; Q2 inflated by two liftings and will swing back
OrganicProduction only +10% QoQ; the true ramp (Cote d'Ivoire) starts Q3, not in the Q2 number
DistributionEstablished offtake in Gabon/Egypt/Cote d'Ivoire; volumes sold, demand not the constraint
What kills itA low-lifting quarter and/or softer Brent collapses revenue regardless of production
05 SNX Td Synnex Corp
$267.46price 8%off high $21.3Bmcap 8dsince 10-Q
+18%2026-02 → +31%2026-05 → +38%2026-08
FUND
47margin flat / CFO-NI 1.85
TECH
100RS +3% vs SPY / vol x1.38
SENT
30insiders -5 / SI 2% / 11 analysts
Wholesale-Computers & Peripheral Equipment & Software
Awaiting analyst pass — numbers only. Research runs after the next screen.
06 HPK Highpeak Energy, Inc.
$8.73price 0%off high $1.1Bmcap 60dsince 10-Q
-30%2025-09 → -21%2026-03 → +26%2026-06
FUND
48margin ? / CFO-NI 26.98
TECH
90RS +15% vs SPY / vol x1.1
SENT
40insiders +0 / SI 51% / 1 analysts
Drilling Oil & Gas Wells
needs human judgement commodity/cyclical

What happenedQ2 2026 revenue was $272.4M (reported 10 Aug 2026), up ~26% YoY vs $216.5M, but production averaged 45.3 MBoe/d - down from ~48.3 MBoe/d FY2025 and below year-ago - so the jump is higher realized oil prices (Q2 2025 realized crude was a weak $63.74/bbl) plus reduced hedging to capture spot, not more barrels. Front-loaded completions (16 completed vs 8 drilled) pushed Q2 volumes 7% above guidance, a timing effect with H2 2026 capex set to fall.

BullNet income swung to $82.3M ($0.59 EPS) from $26.2M YoY, FCF was $37.6M, costs ran 13% below guidance, and H2 2026 capex drops sharply to lift FCF; a Sept 2026 sale process (Evercore) and a ~$450M Danantara preferred deal closing Q4 2026 add hard M&A/financing catalysts.

BearA price-and-hedging recovery off a weak 2025 base, not organic growth - HighPeak cut 2026 capex ~50%, runs one rig/frac crew, and guides FY2026 to 41-44 MBoe/d, below 2025, so production is in managed decline and the 'acceleration' reverses if WTI softens.

NarrativeNarrative is dominated by take-private/M&A: shares jumped ~5.5% on 17 Sept 2026 on a potential sale (Evercore + Texas Capital), plus a ~$450M Danantara preferred with $800M debt commitment to repay the $1.17B term loan, closing Q4 2026. CAUTION: very high short interest (~31-51% of float) makes this a crowded short with real squeeze risk, volatile on M&A headlines rather than fundamentals.

Repeat purchaseN/A - commodity E&P; revenue = volume x price, no recurring customers
OrganicNo - Q2 2026 production 45.3 MBoe/d is down YoY; FY guide 41-44 is below 2025's 48.3
DistributionN/A; Permian takeaway in place but output is intentionally shrinking
What kills itLower WTI/realized prices, declining production on the cut-capex plan, or a buyout closing at a fixed price capping the equity
07 MASS 908 Devices Inc.
$11.55price 10%off high $477Mmcap 59dsince 10-Q
-4%2025-09 → +14%2026-03 → +23%2026-06
FUND
32margin up / CFO-NI -1.22
TECH
90RS +42% vs SPY / vol x1.08
SENT
65insiders -10 / SI 13% / 4 analysts
Laboratory Analytical Instruments/▲ receivables growth outpacing revenue by >20% for 2 quarters▲ annual CFO/NI = -1.22 (< 0.8)
Awaiting analyst pass — numbers only. Research runs after the next screen.
08 MDB Mongodb, Inc.
$371.35price 21%off high $29.9Bmcap 38dsince 10-Q
+19%2025-10 → +25%2026-04 → +30%2026-07
FUND
54margin up
TECH
55RS +6% vs SPY / vol x1.54
SENT
30insiders -3 / SI 4% / 37 analysts
Services-Prepackaged Software
Awaiting analyst pass — numbers only. Research runs after the next screen.
09 DSP Viant Technology Inc.
$13.16price 7%off high n/amcap 60dsince 10-Q
+7%2025-09 → +25%2026-03 → +34%2026-06
FUND
36margin ? / CFO-NI 6.3
TECH
75RS -1% vs SPY / vol x1.85
SENT
30insiders -5 / SI 8% / 11 analysts
Services-Computer Programming, Data Processing, Etc.
Awaiting analyst pass — numbers only. Research runs after the next screen.
10 OOMA Ooma Inc
$20.10price 14%off high $555Mmcap 35dsince 10-Q
+4%2025-10 → +25%2026-04 → +25%2026-07
FUND
40margin flat / CFO-NI 4.29
TECH
50RS -5% vs SPY / vol x1.22
SENT
40insiders -13 / SI 6% / 5 analysts
Services-Computer Processing & Data Preparation
Awaiting analyst pass — numbers only. Research runs after the next screen.

Remaining fresh triggers

6 names passed all filters — unranked detail
TickerCompanyRevenue YoYMcapFlags
RDNTRadnet, Inc.+13% → +22% → +25%$5.4B—
INSWInternational Seaways, Inc.-13% → +77% → +139%$6.0B—
WATWaters Corp /De/+7% → +91% → +113%$42.2B—
PAAPlains All American Pipeline Lp-12% → +9% → +66%$17.2B—
PAGPPlains Gp Holdings Lp-12% → +9% → +66%$5.3B—
SWBISmith & Wesson Brands, Inc.-4% → +17% → +32%$642M—
Not yet live in v0: estimate revisions, Beneish M-Score, SEC enforcement history, organic-vs-acquisition auto-detection. Expect M&A and milestone-revenue noise below the analyst-verified names. Most flagged setups fail — the portfolio maths, not the pick, is the strategy.